>>> US Gapping up

Gapping up
In reaction to strong earnings/guidance:
  • CLWT +40%, EXAS +17.4%, SSKN +15.3%, (guidance), UCTT +12.2%, SHOR +11.6%, (also expanded partnership with ScanSource Communications),TER +11%, MKSI +7.5%, GOV +7.2%, CRY +6.9%, ALSN +6.8%, NOK +6.7%,UAA +6.3%, PYPL +5.8%, GGG +5.7%, BBW +5.6%, NOW +5.4%, YNDX +5.2%, TAL +4.9%, IVTY +4.7%, INTU +4.7%, AUO +4.4%, SSW +4.3%,ASPS +4.1%, ALXN +4%, CSTM +4%, CRHM +3.8%, CBG +3.8%, CRHM +3.8%, POT +3.8%, CAVM +3.6%, BMY +3.5%, XLNX +3.4%, (also raises dividend), AXTI +3.3%, DPZ +3.2%, LKQ +2.7%, STM +2.6%, LYG +2.5%,BWA +2.5%, KKR +2.5%, DVD +2.4%, MMLP +2.3%, TSCO +2.3%, COR +2.3%, F +2.3%, STNG +2.2%, ROG +2.2%, PRLB +2.2%, AOS +1.9%, FSS +1.9%, CMCSA +1.8%, NTRI +1.3%, GG +1.2%, ABBV +1.2%, WLL +1%, CDE +1%, CRR +1%, RTN +1%, TREE +1%, HAWK +0.8%, CME +0.8%, DOW +0.8%
Other news:
  • MDGS +24.6% (announces that the first ten procedures have been performed as the initial phase of the Chinese FDA multi-center MUSE Clinical Study in China)
  • EXAS +17.2% (signs five-year agreement with MDxHealth SA for a collaboration in the growing field of epigenetics and molecular diagnostics)
  • PIP +15.9% (PharmAthene and Altimmune merger was approved for listing on the Nasdaq pending stockholders vote on May 4; expected to commence trading on May 5)
  • WTW +7.5% (Weight Watchers appoints former HSNI CEO Mindy Grossman as its President and CEO effective July 2017)
  • HRB +2.5% (H & R Block filed 19.4 mln returns in the U.S. for fiscal year 2017 through April 19, with Assisted returns -2.5% to 11.8 million, and DIY online returns +6.8% to 5.0 million)
  • RBS +2% (in sympathy with LYG)
  • TRUE +1.5% (prices offering of 9 mln shares of common stock at $16.50 per share)
  • GM +1.2% (in sympathy with F)
  • TRU +0.8% (to offer for sale in an underwritten secondary offering 15,000,000 shares of common stock and purchase of 1,500,000 shares of common stock)
Analyst comments:
  • ALIM +6.8% (initiated with a Buy at Rodman & Renshaw; tgt $4)
  • ONTX +4.8% (initiated with a Buy at Laidlaw; tgt $10),
  • CSCO +2.4% (upgraded to Outperform from Underperform at Credit Suisse)
  • FSLR +1.3% (upgraded to Mkt Perform from Mkt Underperform at JMP Securities)